David R Shprecher1, Charles H Adler2, Nan Zhang3, Holly A Shill4, Christine M Belden5, Erika Driver-Dunckley2, Shyamal H Mehta2, Kathryn J Davis6, Lucia I Sue6, Edward Zamrini5, Thomas G Beach6. 1. Cleo Roberts Center, Banner Sun Health Research Institute, Sun City, AZ, United States. Electronic address: david.shprecher@bannerhealth.com. 2. Department of Neurology, Mayo Clinic College of Medicine, Scottsdale, AZ, United States. 3. Department of Health Science Research, Section of Biostatistics, Mayo Clinic College of Medicine, Scottsdale, AZ, United States. 4. Barrow Neurological Institute, Phoenix, AZ, United States. 5. Cleo Roberts Center, Banner Sun Health Research Institute, Sun City, AZ, United States. 6. Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ, United States.
Abstract
OBJECTIVE: Subjective excessive daytime sleepiness, commonly measured with the Epworth Sleepiness Scale (ESS), is associated with cognitive impairment in Parkinson disease (PD). Significant correlation between subject and informant responses has been reported in neurologically healthy individuals. We sought to assess this correlation in patients with PD. PATIENTS AND METHODS: 854 individuals in the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND) had subject as well as informant-completed ESS completed within one year of a movement disorder exam and cognitive assessment. Correlations were evaluated using Spearman's rank correlation coefficients. RESULTS: Overall, 397/854(46.5 %) were female with mean age of 77.5 (SD 8.3). 572 (67 %) were cognitively normal (CogNL), 135 (15.8 %) had mild cognitive impairment (MCI) and 147 (17.2 %) dementia. Spearman R correlations (all with p < 0.001) between subject and informant ESS responses were 0.73 overall, 0.67 for the CogNL group, 0.79 for the MCI group, 0.79 for those with dementia. Of 175 with clinically probable PD, 115 (65.7 %) were CogNL, 38 had MCI, and 22 (12.6 %) dementia. For subjects with PD correlations (all with p < 0.001) were 0.65 for PD-CogNL, 0.83 for PD-MCI, and 0.70 for those with PD-dementia. CONCLUSION: These significant correlations between subject and informant-completed ESS can be useful in guiding clinical trials designed to assess efficacy of potential treatments for excessive daytime sleepiness for the general population and for patients with PD, even those having cognitive impairment.
OBJECTIVE: Subjective excessive daytime sleepiness, commonly measured with the Epworth Sleepiness Scale (ESS), is associated with cognitive impairment in Parkinson disease (PD). Significant correlation between subject and informant responses has been reported in neurologically healthy individuals. We sought to assess this correlation in patients with PD. PATIENTS AND METHODS: 854 individuals in the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND) had subject as well as informant-completed ESS completed within one year of a movement disorder exam and cognitive assessment. Correlations were evaluated using Spearman's rank correlation coefficients. RESULTS: Overall, 397/854(46.5 %) were female with mean age of 77.5 (SD 8.3). 572 (67 %) were cognitively normal (CogNL), 135 (15.8 %) had mild cognitive impairment (MCI) and 147 (17.2 %) dementia. Spearman R correlations (all with p < 0.001) between subject and informant ESS responses were 0.73 overall, 0.67 for the CogNL group, 0.79 for the MCI group, 0.79 for those with dementia. Of 175 with clinically probable PD, 115 (65.7 %) were CogNL, 38 had MCI, and 22 (12.6 %) dementia. For subjects with PD correlations (all with p < 0.001) were 0.65 for PD-CogNL, 0.83 for PD-MCI, and 0.70 for those with PD-dementia. CONCLUSION: These significant correlations between subject and informant-completed ESS can be useful in guiding clinical trials designed to assess efficacy of potential treatments for excessive daytime sleepiness for the general population and for patients with PD, even those having cognitive impairment.
Authors: Miriam Wienecke; Esther Werth; Rositsa Poryazova; Heide Baumann-Vogel; Claudio L Bassetti; Michael Weller; Daniel Waldvogel; Alexander Storch; Christian R Baumann Journal: J Sleep Res Date: 2012-07-02 Impact factor: 3.981
Authors: Charles H Adler; Joseph G Hentz; Holly A Shill; Marwan N Sabbagh; Erika Driver-Dunckley; Virgilio G H Evidente; Sandra A Jacobson; Thomas G Beach; Bradley Boeve; John N Caviness Journal: Parkinsonism Relat Disord Date: 2011-04-08 Impact factor: 4.891
Authors: Amy W Amara; Lama M Chahine; Chelsea Caspell-Garcia; Jeffrey D Long; Christopher Coffey; Birgit Högl; Aleksandar Videnovic; Alex Iranzo; Geert Mayer; Nancy Foldvary-Schaefer; Ron Postuma; Wolfgang Oertel; Shirley Lasch; Ken Marek; Tanya Simuni Journal: J Neurol Neurosurg Psychiatry Date: 2017-05-29 Impact factor: 10.154
Authors: Tanya Simuni; Chelsea Caspell-Garcia; Christopher Coffey; Lama M Chahine; Shirley Lasch; Wolfgang H Oertel; Geert Mayer; Birgit Högl; Ron Postuma; Aleksandar Videnovic; Amy Willis Amara; Ken Marek Journal: Mov Disord Date: 2015-06-11 Impact factor: 10.338
Authors: Thomas G Beach; Charles H Adler; Lucia I Sue; Geidy Serrano; Holly A Shill; Douglas G Walker; LihFen Lue; Alex E Roher; Brittany N Dugger; Chera Maarouf; Alex C Birdsill; Anthony Intorcia; Megan Saxon-Labelle; Joel Pullen; Alexander Scroggins; Jessica Filon; Sarah Scott; Brittany Hoffman; Angelica Garcia; John N Caviness; Joseph G Hentz; Erika Driver-Dunckley; Sandra A Jacobson; Kathryn J Davis; Christine M Belden; Kathy E Long; Michael Malek-Ahmadi; Jessica J Powell; Lisa D Gale; Lisa R Nicholson; Richard J Caselli; Bryan K Woodruff; Steven Z Rapscak; Geoffrey L Ahern; Jiong Shi; Anna D Burke; Eric M Reiman; Marwan N Sabbagh Journal: Neuropathology Date: 2015-01-26 Impact factor: 1.906
Authors: Jennifer G Goldman; Reena A Ghode; Bichun Ouyang; Bryan Bernard; Christopher G Goetz; Glenn T Stebbins Journal: Parkinsonism Relat Disord Date: 2013-06-02 Impact factor: 4.891